Godin Y, Heiner L, Mark J, Mandel P (1969) Effects of DI-n‐propylacetate, an anticonvulsive compound, on GABA metabolism. J Neurochem 16:869–873. https://doi.org/10.1111/j.1471-4159.1969.tb08975.x
Löscher W (1993) Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain. Neurochem Res 18:485–502. https://doi.org/10.1007/bf00967253
Luder AS, Parks JK, Frerman F, Parker WD (1990) Inactivation of beef brain alpha-ketoglutarate dehydrogenase complex by valproic acid and valproic acid metabolites. Possible mechanism of anticonvulsant and toxic actions. J Clin Invest 86:1574–1581. https://doi.org/10.1172/JCI114877
McCormick DA (1989) GABA as an inhibitory neurotransmitter in human cerebral cortex. J Neurophysiol 62:1018–1027. https://doi.org/10.1152/jn.1989.62.5.1018
Stratton MS, Searcy BT, Tobet SA (2011) GABA regulates corticotropin releasing hormone levels in the paraventricular nucleus of the hypothalamus in newborn mice. Physiol Behav 104:327. https://doi.org/10.1016/J.PHYSBEH.2011.01.003
Tran V, Hatalski CG, Yan XX, Baram TZ (1999) Effects of blocking GABA degradation on corticotropin-releasing hormone gene expression in selected brain regions. Epilepsia 40:1190–1197
Miller L, Foradori CD, Lalmansingh AS et al (2011) Histone deacetylase 1 (HDAC1) participates in the down-regulation of corticotropin releasing hormone gene (crh) expression. Physiol Behav 104:312–320. https://doi.org/10.1016/J.PHYSBEH.2011.03.026
Zhang L, Li H, Li S, Zou X (2016) Reproductive and metabolic abnormalities in women taking valproate for bipolar disorder: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 202:26–31. https://doi.org/10.1016/j.ejogrb.2016.04.038
Xiaotian X, Hengzhong Z, Yao X et al (2013) Effects of antiepileptic drugs on reproductive endocrine function, sexual function and sperm parameters in Chinese Han men with epilepsy. J Clin Neurosci 20:1492–1497. https://doi.org/10.1016/j.jocn.2012.11.028
Glister C, Satchell L, Michael AE et al (2012) The anti-epileptic drug valproic acid (VPA) inhibits steroidogenesis in bovine theca and granulosa cells in vitro. PLoS One 7:e49553. https://doi.org/10.1371/journal.pone.0049553
Brion L, Gorostizaga A, Gómez NV et al (2011) Valproic acid alters mitochondrial cholesterol transport in Y1 adrenocortical cells. Toxicol Vitr 25:7–12. https://doi.org/10.1016/J.TIV.2010.08.006
Pesaresi M, Maschi O, Giatti S et al (2010) Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats. Horm Behav 57:46–55. https://doi.org/10.1016/j.yhbeh.2009.04.008
Göttlicher M, Minucci S, Zhu P et al (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20:6969–6978. https://doi.org/10.1093/emboj/20.24.6969
Bilo L, Meo R (2008) Polycystic ovary syndrome in women using valproate: a review. Gynecol Endocrinol 24:562–570. https://doi.org/10.1080/09513590802288259
Pennell PB (2009) Hormonal aspects of epilepsy. Neurol Clin 27:941–965
Taubøll E, Sveberg L, Svalheim S (2015) Interactions between hormones and epilepsy. Seizure 28:3–11
Banks WA (2012) Brain meets body: the blood-brain barrier as an endocrine interface. Endocrinology 153:4111–4119. https://doi.org/10.1210/en.2012-1435
Diotel N, Charlier TD, Lefebvre d’Hellencourt C et al (2018) Steroid transport, local synthesis, and signaling within the brain: roles in neurogenesis, neuroprotection, and sexual behaviors. Front Neurosci 12:84. https://doi.org/10.3389/fnins.2018.00084
Mellon SH, Vaudry H (2001) Biosynthesis of neurosteroids and regulation of their sysnthesis. Int Rev Neurobiol 46:33–78. https://doi.org/10.1016/S0074-7742(01)46058-2
Akwa Y, Morfin RF, Robel P, Baulieu EE (1992) Neurosteroid metabolism. 7 alpha-Hydroxylation of dehydroepiandrosterone and pregnenolone by rat brain microsomes. Biochem J 288(Pt 3):959–964. https://doi.org/10.1042/BJ2880959
Baulieu EE (1991) Neurosteroids: a new function in the brain. Biol Cell 71:3–10
Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J 6:2311–2322
Taubøll E, Gregoraszczuk EL, Kołodziej A et al (2003) Valproate inhibits the conversion of testosterone to estradiol and acts as an apoptotic agent in growing porcine ovarian follicular cells. Epilepsia 44:1014–1021. https://doi.org/10.1046/j.1528-1157.2003.60702.x
Taubøll E, Wójtowicz AK, Ropstad E, Gregoraszczuk EL (2002) Valproate irreversibly alters steroid secretion patterns from porcine follicular cells in vitro. Reprod Toxicol 16:319–325. https://doi.org/10.1016/S0890-6238(02)00020-5
Von Krogh K, Harjen H, Almås C et al (2010) The effect of valproate and levetiracetam on steroidogenesis in forskolin-stimulated H295R cells. Epilepsia 51:2280–2288. https://doi.org/10.1111/j.1528-1167.2010.02702.x
Gregoraszczuk E, Wójtowicz AK, Taubøll E, Ropstad E (2000) Valproate-induced alterations in testosterone, estradiol and progesterone secretion from porcine follicular cells isolated from small- and medium-sized ovarian follicles. Seizure 9:480–485. https://doi.org/10.1053/SEIZ.2000.0443
Inada H, Chihara K, Yamashita A et al (2012) Evaluation of ovarian toxicity of sodium valproate (VPA) using cultured rat ovarian follicles. J Toxicol Sci 37:587–594. https://doi.org/10.2131/jts.37.587
Sukhorum W, Iamsaard S (2017) Changes in testicular function proteins and sperm acrosome status in rats treated with valproic acid. Reprod Fertil Dev 29:1585. https://doi.org/10.1071/RD16205
Tringali G, Aubry JM, Moscianese K et al (2004) Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission. J Psychiatry Neurosci 29:459–466
Stout S, Owens MJ, Lindsey KP et al (2001) Effects of sodium valproate on corticotropin-releasing factor systems in rat brain. Neuropsychopharmacology 24:624–631. https://doi.org/10.1016/S0893-133X(00)00243-8
Gilmor ML, Skelton KH, Nemeroff CB, Owens MJ (2003) The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems. J Pharmacol Exp Ther 305:434–439. https://doi.org/10.1124/jpet.102.045419
Hsing AW, Stanczyk FZ, Bélanger A et al (2007) Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry. Cancer Epidemiol Biomarkers Prev 16:1004–1008. https://doi.org/10.1158/1055-9965.EPI-06-0792
Wood L, Ducroq DH, Fraser HL et al (2008) Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays. Ann Clin Biochem 45:380–388. https://doi.org/10.1258/acb.2007.007119
Dubey RK, Jackson EK (2001) Invited review: cardiovascular protective effects of 17β-estradiol metabolites. J Appl Physiol 91:1868–1883. https://doi.org/10.1152/jappl.2001.91.4.1868
Weaver ICG, Meaney MJ, Szyf M (2006) Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proc Natl Acad Sci 103:3480–3485. https://doi.org/10.1073/pnas.0507526103
Murray EK, Hien A, de Vries GJ, Forger NG (2009) Epigenetic control of sexual differentiation of the bed nucleus of the stria terminalis. Endocrinology 150:4241–4247. https://doi.org/10.1210/en.2009-0458
Tsai H-W, Grant PA, Rissman EF (2009) Sex differences in histone modifications in the neonatal mouse brain. Epigenetics 4:47–53
Bell MR (2018) Comparing postnatal development of gonadal hormones and associated social behaviors in rats, mice, and humans. Endocrinology 159:2596–2613. https://doi.org/10.1210/en.2018-00220